Delivery Order 36C24821D0025-36C24825N0352
Award Date
2/1/25
Potential Completion Date
1/31/26
Potential Value
$288K
Federal Agency
Veterans Integrated Service Network 8
Awardee
Cytopath Biopsy Lab Inc.
Ultimate Awardee
Not listed
NAICS Category
621511 - Medical Laboratories
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Port Chester, NY 10573, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $710,168.17 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA), Veterans Integrated Service Network 21, to Cytopath Biopsy Lab Inc. (operating as Cblpath) for the ThyroSeq V3 Classifier CPT molecular diagnostic testing service. The contract has an ultimate completion date of August 4, 2029 and exercises the first option year. This award is not associated with a set-aside program. Cytopath Biopsy Lab Inc. is a for-profit organization...
This is a firm fixed price delivery order contract awarded by the Veterans Integrated Service Network 4 (VISN 4), which is part of the U.S. Department of Veterans Affairs (VA), to Cytopath Biopsy Lab Inc., doing business as Cblpath. The contract is for the provision of cytopathology and ThyroSeq genomic testing services, with a ceiling value of $8,000. Cytopath Biopsy Lab Inc. is a for-profit organization that specializes in cancer screening and diagnostic laboratory services, particularly for...
This is a federal contract award by the U.S. Department of Veterans Affairs (VA) to Cytopath Biopsy Lab Inc., operating under the trade name Cblpath. The $148,000 firm-fixed-price delivery order contract is for ThyroSeq genetic testing services to support cancer screening and diagnosis programs for veterans and active military personnel. The contract is not set aside for any specific business category. Cytopath Biopsy Lab Inc. is a for-profit organization specializing in anatomic pathology and...
This is a $535,610.00 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Cytopath Biopsy Lab Inc., operating under the trade name Cblpath. The contract is for thyroid cancer testing services, specifically the company's proprietary ThyroSeq molecular diagnostic testing, to support cancer screening and diagnosis programs for veterans and active military personnel. The contract has an ultimate completion date of September 30, 2029 and was awarded...
The Department of Veterans Affairs (VA) Veterans Integrated Service Network 22 awarded a firm-fixed-price purchase order contract to Cytopath Biopsy Lab Inc., doing business as Cblpath, to provide ThyroSeq molecular testing services. The $2,250,000.00 contract has a period of performance from October 13, 2023 to October 12, 2025. Cytopath Biopsy Lab Inc. is a provider of specialized anatomic pathology and molecular diagnostic laboratory services, with expertise in cancer screening and...
This is a firm fixed price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Cytopath Biopsy Lab Inc., doing business as Cblpath, to provide ThyroSeq laboratory tests to determine thyroid nodule malignancy for surgical decision making. The $72,000.00 award is part of an Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle between the VA and Cytopath Biopsy Lab Inc. to support cancer screening and diagnosis programs within the VA healthcare network. The contract...
This is a firm fixed-price delivery order contract awarded by the Veterans Integrated Service Network 4 (VISN 4), a civilian agency within the Department of Veterans Affairs (VA), to Cytopath Biopsy Lab Inc. (operating as Cblpath), a for-profit organization. The $28,000.00 contract is for cytopathology and ThyroSeq genetic testing services to support cancer screening and diagnosis programs for veterans and active military personnel. The contract has an ultimate completion date of May 31, 2025...
This is a firm fixed price contract awarded by the Department of Veterans Affairs (VA) to Cytopath Biopsy Lab Inc., doing business as Cblpath, for $428,000.00 to provide THYROSEC TESTING services. The contract supports the VA's cancer screening and diagnosis programs, with Cytopath Biopsy Lab providing specialized thyroid cancer diagnostic testing using its ThyroSeq molecular diagnostic platform. This includes genetic mutation analysis to evaluate malignancy of thyroid nodules detected in...
This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cytopath Biopsy Lab Inc., doing business as Cblpath, to provide ThyroSeq genetic testing services for the VA's Veterans Integrated Service Network (VISN) 22. The $366,000 contract will support thyroid cancer screening and diagnosis programs at VA healthcare facilities in California, New Mexico, Arizona, and other regional locations. The original solicitation was a...
This is a firm fixed price contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cytopath Biopsy Lab Inc., doing business as Cblpath, to provide ThyroSeq V2 next generation lab testing services for Veterans Integrated Service Network 1. The contract has a potential value of $717,000.00 and a period of performance through September 30, 2021. This contract is not associated with a set-aside program. Cytopath Biopsy Lab Inc. is a for-profit provider of...